Press Releases
The Case for Federal Investment in Cell-Based Therapies for Patients with COVID-19
A new report released by Alliance for Cell Therapy Now, an independent, non-profit organization guided by leaders representing academic and medical institutions, industry innovators, and patients, summarizes clinical studies that are now underway that explore the use...
Alliance for Cell Therapy Now Commends Congress for Regenerative Medicine and Cell Therapy Provisions in FY 2021 Spending Bill: Additional Support for Clinical Trials for COVID Patients is Still Needed
Washington, DC (December 30, 2020) – Leaders of Alliance for Cell Therapy Now (ACT Now)—including representatives of academic and medical institutions, industry innovators, and patients—applaud Congress for its inclusion of important provisions in the final FY 2021...